Professional Documents
Culture Documents
Cross sectional?
1. Odds ratio
2. Relative risk
3.Chi square test ***
4. Attributable risk and Chi square test
5. odds ratio and attributable risk
cross sectional: use CHI SQUARE
Cohort: use RR or AR
Case control: use ODD's RATIO
Which is the best study to find out the state of Vitamin D
deficiency in Australia?
a..cohort
b..case control
c..case study
d..Cross-‐sectional study.***
For Prevalance Cross Sectional Study ..... to check
incidence Cohort .... So D here
In a village of 3000 people, 500 get Congo Hemorrhagic fever.
450 eventually recover from the disease in the next 4 weeks
while 50 died. What is the case fatility rate for this disease?
1. 10 ***
2. 20
3.35
4.50
5. 200
Case fatality rate = # of deaths from a specific cause /
total number of cases with same disease...
50 / 500 = 10 (A)
You are a doctor in a town ,where 6people out of 100 are non
smoker.What are the
chances of stroke.the chances of stroke in smoker is 50%more
than non smoker .Now
the pharmaceutical company is introducing a medicine which
reduces the chances of
stroke upto 1/3rd in smoker population .What is the percentage
of the stroke population
will get stroke
a)3%
b)6% ***
c)9%
d)12%
e)20%
a. RCT
b. Cohort
c. A retrospective case-control study ***
d. Case report
e. systemic review
You find there are more and more diabetics in your
practice and you want to do a research about
how many people are diabetic. What is the best study
design?
a. Cohort study
b. Case-control study
c. Randomized-control trial
d. Cross-section study ***
A) Cohort ***
B) Randomized Controlled
C) Case Control
D) Case series
E) Observational
least imp study to look for effectiveness of ccf Rx?
a,case control
b, case series ***
c, cohort
d,RCT
e, Systemic Review
A study wish to make a relation btw the fatigue in track
car driver in high ways & the incidence of MVA happen.
wt is the most suitable method to carry out study?
a, cohort
b, case control
c, RCT
D,cross sectional
E,case study
1.Case-control study
2.Case series
4.Cross-sectional survey
2009 2010
Antibody +ve cases 10 15
Antigen +ve cases 40 55
pecificty-confirmatory.
What study would you do if you want to find out the efficacy of
a vaccine
on a group of people?
a) Randomised controlled trials ***
b) Cohort study
c) Case control study
d) Cross sectional study
A new drug was launched in the market after getting over with
the non-inferiority trials. The drug,s P value at the end of the
trial was <0.03. What does this P value show!
1. Drug is superior to other drugs
2. Drug is inferior to other drugs
3. The drug is inferior to other drugs
4. The drug has better adverse event profile
5. The new drug has better efficacy.
A new drug is discovered, which affects the progression of the
disease, but not the
mortality. Which is the most appropriate statement?.
a. increase incidence
b. decrease incidence
c. Increase prevalence ***
d. decrease prevalence
A pharmaceutical company before the start of the trial got
approval from ethical committee to use a new anti-cancer drug
for ca.Pancreas. The ethical committee gave approval and set
the target P value< or = 0.02, for the drug to be superior to
other drugs. At the end of the trial, the company claimed about
the efficacy of the new drug to be superior to all other available
drugs in the market and P value at the end of the trial was =
0.04. What does this P value show here.
1. New drug is safer as compared to other drugs.
2. New drug is as useful as other drugs with fewer side effects
3. new drug is superior to other drugs
4. New drugs is not to superior to other drugs
5. New drug is inferior to other drugs
if a p value is less than 0.05 then diffe is significant ,
But here they changed the standard and set it at 0.02
instead of 0.05... Here you just forget about this 0.05.
Now compare 0.02 and 0.04 and conclude your result
from this!!... if i had not given you 0.02 as the
acceptable P value for this trial then it was 0.05 but
now i have given you a standard P value so why you
bather about 0.05 then anymore... 0.04> 0.02 so it
means drug is not superior to other drugs.. For
superiority of the drug, it should have been trial final P
value < Standard P value. Which is not the case here....
Here only two things should confuse you, Drug is
inferior to other drugs and drug is superior to other
drugs. Here they can ask you that drug is
inferior, so your justification for rejecting this is that as
the trial was for superiority, so we can only comment
on its superiority status here, not inferiority status
P value less thn 0.01 means something is highly
specific, i.e there's only 1% chance of occurrence of an
observed difference. The standard p value is 0.05 which
means that theres 5% chance of difference to occur. If
p value exceeds 0.05 in a research, the test hypothesis
is nullified.
You find there are more and more diabetics in your practice
and you want to do a research about
how many people are diabetic. What is the best study design?
a. Cohort study
b. Case-control study
c. Randomized-control trial
d. Cross-section study***
Average BP is 130 +/- 25. about 95% people will lie between :
a. 115-155
b. 80-180***
c. 95-100
for 100% its +/-D, for 95% its +/-2D
for 50% it is +/- 3SD
A) Cohort ***
B) Randomized Controlled
C) Case Control
D) Case series
E) Observational
least imp study to look for effectiveness of ccf Rx?
a,case control
b, case series ***
c, cohort
d,RCT
e, Systemic Review
c, RCT
D,cross sectional
E,case study
here we say that 100 are positve for the test (TP+FP).
of these 100 30% are False Positive which means that
True Positive (70) and False Positive (30). Then we
have remaining 1000 of which 10% are False
Negative,this comes out as 100. Then lastly we have T-
(900). So the 2x2 table is TP (70) FP (30) F- (100) T-
(900). Now we want to know the positive predictive
value (likelihood that a positive result in test indicates
disease). Formula is (TP/(TP+FP)). so
(70)/(70+30)=70%
1.Case-control study
2.Case series
3.Cohort study
4.Cross-sectional survey